2021 Q1 Form 10-Q Financial Statement

#000113754721000014 Filed on April 30, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $8.520M $9.494M
YoY Change -10.26% -8.86%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $360.0K $340.0K
YoY Change 5.88% -5.56%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $473.0K $761.0K
YoY Change -37.84% -20.48%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.948M $3.862M
YoY Change -49.56% -31.4%
Income Tax $537.0K $1.108M
% Of Pretax Income 27.57% 28.69%
Net Earnings $1.411M $2.754M
YoY Change -48.77% -31.27%
Net Earnings / Revenue 16.56% 29.01%
Basic Earnings Per Share $0.08 $0.16
Diluted Earnings Per Share $0.08 $0.16
COMMON SHARES
Basic Shares Outstanding 17.01M shares 16.97M shares
Diluted Shares Outstanding 17.03M shares 16.99M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $307.9M $199.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $11.60M $12.50M
YoY Change -7.2% -2.34%
Goodwill $4.488M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.200M $2.600M
YoY Change 23.08% -18.75%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.187B $977.2M
YoY Change 21.46% 1.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K
YoY Change 0.0%
Accrued Expenses $2.800M $3.300M
YoY Change -15.15% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.800M $3.400M
YoY Change -17.65% 0.0%
LONG-TERM LIABILITIES
Long-Term Debt $11.00M $8.500M
YoY Change 29.41% -19.05%
Other Long-Term Liabilities $8.000M $7.500M
YoY Change 6.67% 1.35%
Total Long-Term Liabilities $19.00M $16.00M
YoY Change 18.75% -10.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.800M $3.400M
Total Long-Term Liabilities $19.00M $16.00M
Total Liabilities $1.070B $859.8M
YoY Change 24.4% 0.82%
SHAREHOLDERS EQUITY
Retained Earnings $58.67M
YoY Change
Common Stock $59.44M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $117.3M $117.4M
YoY Change
Total Liabilities & Shareholders Equity $1.187B $977.2M
YoY Change 21.46% 1.37%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $1.411M $2.754M
YoY Change -48.77% -31.27%
Depreciation, Depletion And Amortization $360.0K $340.0K
YoY Change 5.88% -5.56%
Cash From Operating Activities $4.626M $4.812M
YoY Change -3.87% 70.46%
INVESTING ACTIVITIES
Capital Expenditures $143.0K $242.0K
YoY Change -40.91% -320.0%
Acquisitions
YoY Change
Other Investing Activities -$83.90M -$43.92M
YoY Change 91.03% -474.74%
Cash From Investing Activities -$84.05M -$44.16M
YoY Change 90.32% -480.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $93.26M $20.21M
YoY Change 361.52% -22.08%
NET CHANGE
Cash From Operating Activities $4.626M $4.812M
Cash From Investing Activities -$84.05M -$44.16M
Cash From Financing Activities $93.26M $20.21M
Net Change In Cash $13.84M -$19.14M
YoY Change -172.3% -147.42%
FREE CASH FLOW
Cash From Operating Activities $4.626M $4.812M
Capital Expenditures $143.0K $242.0K
Free Cash Flow $4.483M $4.570M
YoY Change -1.9% 55.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001137547
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
000-32897
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
UNITED SECURITY BANCSHARES
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-2112732
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2126 Inyo Street
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Fresno
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
93721
CY2021Q1 dei City Area Code
CityAreaCode
559
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
248-4943
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17010288 shares
CY2021Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
34257000 USD
CY2020Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
29490000 USD
CY2021Q1 ubfo Due From Frb Interest Bearing Cash
DueFromFrbInterestBearingCash
273652000 USD
CY2020Q4 ubfo Due From Frb Interest Bearing Cash
DueFromFrbInterestBearingCash
264579000 USD
CY2021Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
307909000 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
294069000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
143549000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
82341000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
3791000 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
3851000 USD
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
147340000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
86192000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
675694000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
655411000 USD
CY2021Q1 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
-1205000 USD
CY2020Q4 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
-1064000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8549000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8522000 USD
CY2021Q1 us-gaap Notes Receivable Net
NotesReceivableNet
665940000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
645825000 USD
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
8895000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9110000 USD
CY2021Q1 us-gaap Interest Receivable
InterestReceivable
8582000 USD
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
8164000 USD
CY2021Q1 us-gaap Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
4841000 USD
CY2020Q4 us-gaap Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
5004000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
4488000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4488000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3235000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2907000 USD
CY2021Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
21766000 USD
CY2020Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
20715000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2733000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2864000 USD
CY2021Q1 us-gaap Other Assets
OtherAssets
11207000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
13316000 USD
CY2021Q1 us-gaap Assets
Assets
1186936000 USD
CY2020Q4 us-gaap Assets
Assets
1092654000 USD
CY2021Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
429005000 USD
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
391897000 USD
CY2021Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
618776000 USD
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
560754000 USD
CY2021Q1 us-gaap Deposits
Deposits
1047781000 USD
CY2020Q4 us-gaap Deposits
Deposits
952651000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2838000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2967000 USD
CY2021Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
8001000 USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
8305000 USD
CY2021Q1 us-gaap Subordinated Debt
SubordinatedDebt
10983000 USD
CY2020Q4 us-gaap Subordinated Debt
SubordinatedDebt
10924000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
1069603000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
974847000 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17010288 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17010288 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17009883 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17009883 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
59443000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
59397000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
58673000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
59138000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-783000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-728000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
117333000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
117807000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1186936000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1092654000 USD
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
8071000 USD
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
8499000 USD
CY2021Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
387000 USD
CY2020Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
428000 USD
CY2021Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
62000 USD
CY2020Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
567000 USD
CY2021Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8520000 USD
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9494000 USD
CY2021Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
427000 USD
CY2020Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
664000 USD
CY2021Q1 us-gaap Interest Expense Loans From Other Federal Home Loan Banks
InterestExpenseLoansFromOtherFederalHomeLoanBanks
46000 USD
CY2020Q1 us-gaap Interest Expense Loans From Other Federal Home Loan Banks
InterestExpenseLoansFromOtherFederalHomeLoanBanks
97000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
473000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
761000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8047000 USD
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8733000 USD
CY2021Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
375000 USD
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1707000 USD
CY2021Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
7672000 USD
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
7026000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
656000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
728000 USD
CY2021Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
132000 USD
CY2020Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
131000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-60000 USD
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
15000 USD
CY2021Q1 ubfo Gain Losson Fair Value Optionof Financial Liability
GainLossonFairValueOptionofFinancialLiability
-1033000 USD
CY2020Q1 ubfo Gain Losson Fair Value Optionof Financial Liability
GainLossonFairValueOptionofFinancialLiability
1498000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
13000 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2021Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
133000 USD
CY2020Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
208000 USD
CY2021Q1 us-gaap Noninterest Income
NoninterestIncome
-159000 USD
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
2580000 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3024000 USD
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2995000 USD
CY2021Q1 us-gaap Occupancy Net
OccupancyNet
856000 USD
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
853000 USD
CY2021Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
87000 USD
CY2020Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
112000 USD
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
827000 USD
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
855000 USD
CY2021Q1 ubfo Regulatory Assessments Expense Benefit
RegulatoryAssessmentsExpenseBenefit
166000 USD
CY2020Q1 ubfo Regulatory Assessments Expense Benefit
RegulatoryAssessmentsExpenseBenefit
85000 USD
CY2021Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
92000 USD
CY2020Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
94000 USD
CY2021Q1 ubfo Correspondent Bank Service Charges
CorrespondentBankServiceCharges
19000 USD
CY2020Q1 ubfo Correspondent Bank Service Charges
CorrespondentBankServiceCharges
15000 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-25000 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-153000 USD
CY2021Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
469000 USD
CY2020Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
582000 USD
CY2021Q1 us-gaap Noninterest Expense
NoninterestExpense
5565000 USD
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
5744000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1948000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3862000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
537000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1108000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1411000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2754000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17010131 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16974100 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17026752 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16994727 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1411000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2754000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1074000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-125000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
24000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
20000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax
972000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax
755000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-78000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
650000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-317000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-37000 USD
CY2021Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
7000 USD
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
6000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodTax
287000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodTax
223000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-55000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
458000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1356000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3212000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
115988000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
35572 shares
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
458000 USD
CY2020Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1867000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
78000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2754000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
117410000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
47572 shares
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-227000 USD
CY2020Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2020Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1866000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
131000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2012000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
117460000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
44568 shares
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
81000 USD
CY2020Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2020Q3 us-gaap Dividends Common Stock
DividendsCommonStock
1867000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
108000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2271000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
118053000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
44568 shares
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-408000 USD
CY2020Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2020Q4 us-gaap Dividends Common Stock
DividendsCommonStock
1870000 USD
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2020Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
108000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1924000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
117807000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
11924 shares
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-55000 USD
CY2020Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1876000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
46000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1411000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
117333000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
41424 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1411000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2754000 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
375000 USD
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1707000 USD
CY2021Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
358000 USD
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
343000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
-129000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
-146000 USD
CY2021Q1 ubfo Amortizationof Investment Securities
AmortizationofInvestmentSecurities
233000 USD
CY2020Q1 ubfo Amortizationof Investment Securities
AmortizationofInvestmentSecurities
219000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
418000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
77000 USD
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1000 USD
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-9000 USD
CY2021Q1 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
141000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-290000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-740000 USD
CY2020Q1 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-741000 USD
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-842000 USD
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-665000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-60000 USD
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
15000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
46000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
77000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-18000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
666000 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-113000 USD
CY2021Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
132000 USD
CY2020Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
131000 USD
CY2021Q1 ubfo Gain Loss On Fair Value Of Financial Instruments Net Pretax
GainLossOnFairValueOfFinancialInstrumentsNetPretax
-1033000 USD
CY2020Q1 ubfo Gain Loss On Fair Value Of Financial Instruments Net Pretax
GainLossOnFairValueOfFinancialInstrumentsNetPretax
1498000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1113000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1625000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4626000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4812000 USD
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
68156000 USD
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
23020000 USD
CY2021Q1 ubfo Principal Paymentsof Availablefor Sale Securities
PrincipalPaymentsofAvailableforSaleSecurities
5641000 USD
CY2020Q1 ubfo Principal Paymentsof Availablefor Sale Securities
PrincipalPaymentsofAvailableforSaleSecurities
5293000 USD
CY2021Q1 us-gaap Payments To Acquire Loans And Leases Held For Investment
PaymentsToAcquireLoansAndLeasesHeldForInvestment
20631000 USD
CY2020Q1 us-gaap Payments To Acquire Loans And Leases Held For Investment
PaymentsToAcquireLoansAndLeasesHeldForInvestment
26886000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
163000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
895000 USD
CY2021Q1 us-gaap Payments To Acquire Limited Partnership Interests
PaymentsToAcquireLimitedPartnershipInterests
0 USD
CY2020Q1 us-gaap Payments To Acquire Limited Partnership Interests
PaymentsToAcquireLimitedPartnershipInterests
201000 USD
CY2021Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
920000 USD
CY2020Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
0 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
143000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
242000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-84046000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44161000 USD
CY2021Q1 us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
93779000 USD
CY2020Q1 us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
25727000 USD
CY2021Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
1351000 USD
CY2020Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-3653000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1870000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1867000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
93260000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20207000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13840000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19142000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
294069000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218995000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
307909000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
199853000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
143729000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1172000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1352000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
143549000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
81448000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1134000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
241000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
82341000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1759000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1767000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
478000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
477000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
32547000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
32223000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
48200000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
47835000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
60745000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
61247000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
143729000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
143549000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
CY2020Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2021Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
50372000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1142000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
25076000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
210000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
75448000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1352000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
9043000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
74000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
18647000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
167000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
27690000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
241000 USD
CY2021Q1 ubfo Number Of General Segments For The Segregation Of Portfolio
NumberOfGeneralSegmentsForTheSegregationOfPortfolio
2 segment
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-60000 USD
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
15000 USD
CY2020Q4 us-gaap Trading Securities
TradingSecurities
0 USD
CY2021Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0 USD
CY2021Q1 us-gaap Trading Securities
TradingSecurities
0 USD
CY2020Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
675694000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
655411000 USD
CY2021Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
12343000 USD
CY2021Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
663351000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
675694000 USD
CY2021Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
234000 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
11126000 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
644285000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
655411000 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
513000 USD
CY2021Q1 ubfo Period Of Default Minimum
PeriodOfDefaultMinimum
P90D
CY2021Q1 ubfo Period Of Default Minimum
PeriodOfDefaultMinimum
P90D
CY2021Q1 ubfo Number Of Monthly Payments To Demonstrate Repayment Ability
NumberOfMonthlyPaymentsToDemonstrateRepaymentAbility
6 payment
CY2021Q1 us-gaap Financing Receivable Loan In Process
FinancingReceivableLoanInProcess
0 USD
CY2020Q4 us-gaap Financing Receivable Loan In Process
FinancingReceivableLoanInProcess
0 USD
CY2021Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
11388000 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
11496000 USD
CY2021Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
13065000 USD
CY2021Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
12419000 USD
CY2021Q1 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
652000 USD
CY2021Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
13071000 USD
CY2021Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
188000 USD
CY2021Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
14223000 USD
CY2021Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
94000 USD
CY2021Q1 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
6000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
13370000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
12694000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
682000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
13376000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
209000 USD
CY2020 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
15374000 USD
CY2020 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
399000 USD
CY2020 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
6000 USD
CY2021Q1 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
69000 USD
CY2020Q1 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
81000 USD
CY2021Q1 ubfo Financing Receivable Periodof Successful Payment History Usedfor Restructured Loan Accrual Status
FinancingReceivablePeriodofSuccessfulPaymentHistoryUsedforRestructuredLoanAccrualStatus
P6M
CY2020Q1 ubfo Financing Receivable Modifications Numberof Contracts During Period2
FinancingReceivableModificationsNumberofContractsDuringPeriod2
1 contract
CY2020Q1 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
179000 USD
CY2020Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
179000 USD
CY2020Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0 contract
CY2020Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0 USD
CY2021Q1 ubfo Number Of Restructured Loans
NumberOfRestructuredLoans
6 loan
CY2021Q1 ubfo Total Restructured Loans
TotalRestructuredLoans
3211000 USD
CY2020Q4 ubfo Number Of Restructured Loans
NumberOfRestructuredLoans
7 loan
CY2020Q4 ubfo Total Restructured Loans
TotalRestructuredLoans
3426000 USD
CY2020Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
3426000 USD
CY2021Q1 ubfo Financing Receivable Modifications Additions
FinancingReceivableModificationsAdditions
0 USD
CY2021Q1 ubfo Financing Receivables Impaired Troubled Debt Restructuring Principal Additions Reductions
FinancingReceivablesImpairedTroubledDebtRestructuringPrincipalAdditionsReductions
215000 USD
CY2021Q1 ubfo Financing Receivables Impaired Troubled Debt Restructuring Credit Losses Write Offs
FinancingReceivablesImpairedTroubledDebtRestructuringCreditLossesWriteOffs
0 USD
CY2021Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
3211000 USD
CY2021Q1 ubfo Financing Receivable Modification Allowance For Loan Losses
FinancingReceivableModificationAllowanceForLoanLosses
188000 USD
CY2021Q1 ubfo Financing Receivable Modifications Defaults
FinancingReceivableModificationsDefaults
0 USD
CY2019Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
5187000 USD
CY2020Q1 ubfo Financing Receivable Modifications Additions
FinancingReceivableModificationsAdditions
179000 USD
CY2020Q1 ubfo Financing Receivables Impaired Troubled Debt Restructuring Principal Additions Reductions
FinancingReceivablesImpairedTroubledDebtRestructuringPrincipalAdditionsReductions
112000 USD
CY2020Q1 ubfo Financing Receivables Impaired Troubled Debt Restructuring Credit Losses Write Offs
FinancingReceivablesImpairedTroubledDebtRestructuringCreditLossesWriteOffs
0 USD
CY2020Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
5254000 USD
CY2020Q1 ubfo Financing Receivable Modification Allowance For Loan Losses
FinancingReceivableModificationAllowanceForLoanLosses
532000 USD
CY2020Q1 ubfo Financing Receivable Modifications Defaults
FinancingReceivableModificationsDefaults
0 USD
CY2021Q1 ubfo Number Of Risk Rating Approaches
NumberOfRiskRatingApproaches
2 rating
CY2021Q1 ubfo Numberof Loan Portfolio Segment
NumberofLoanPortfolioSegment
10 segment
CY2021Q1 ubfo Numberof Loans Entity Experienced Losses
NumberofLoansEntityExperiencedLosses
3 loan
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8522000 USD
CY2021Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
375000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
392000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
44000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
348000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8549000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
188000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
8361000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8549000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7908000 USD
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1707000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
509000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
14000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
495000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9120000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
607000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
8513000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9120000 USD
CY2021Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
13071000 USD
CY2021Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
662623000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
675694000 USD
CY2020Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
15916000 USD
CY2020Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
607849000 USD
CY2020Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
623765000 USD
CY2021Q1 us-gaap Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now
DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW
451827000 USD
CY2020Q4 us-gaap Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now
DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW
402566000 USD
CY2020Q4 us-gaap Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now
DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW
402566000 USD
CY2021Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
429005000 USD
CY2021Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
429005000 USD
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
391897000 USD
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
391897000 USD
CY2021Q1 us-gaap Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now
DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW
451827000 USD
CY2021Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
104078000 USD
CY2021Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
104078000 USD
CY2020Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
96669000 USD
CY2020Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
96669000 USD
CY2021Q1 ubfo Time Deposits Less Than250000
TimeDepositsLessThan250000
41624000 USD
CY2021Q1 ubfo Time Deposits Less Than250000
TimeDepositsLessThan250000
41624000 USD
CY2020Q4 ubfo Time Deposits Less Than250000
TimeDepositsLessThan250000
40302000 USD
CY2020Q4 ubfo Time Deposits Less Than250000
TimeDepositsLessThan250000
40302000 USD
CY2021Q1 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
21247000 USD
CY2021Q1 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
21247000 USD
CY2020Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
21217000 USD
CY2020Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
21217000 USD
CY2021Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
618776000 USD
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
560754000 USD
CY2021Q1 us-gaap Deposits
Deposits
1047781000 USD
CY2020Q4 us-gaap Deposits
Deposits
952651000 USD
CY2021Q1 us-gaap Federal Home Loan Bank Advances Current
FederalHomeLoanBankAdvancesCurrent
0 USD
CY2020Q4 us-gaap Federal Home Loan Bank Advances Current
FederalHomeLoanBankAdvancesCurrent
0 USD
CY2021Q1 ubfo Lessee Operating Lease Number Of Contracts
LesseeOperatingLeaseNumberOfContracts
12 contract
CY2021Q1 ubfo Lessee Financing Lease Number Of Contracts
LesseeFinancingLeaseNumberOfContracts
0 contract
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
168000 USD
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
190000 USD
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
80000 USD
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
71000 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
248000 USD
CY2020Q1 us-gaap Lease Cost
LeaseCost
261000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
166000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M28D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0516
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
668000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
677000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
669000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
452000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
266000 USD
CY2021Q1 ubfo Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
543000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3275000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
437000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2838000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
473000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.11
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1876000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
772000 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
0 USD
CY2020Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
1008000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
24000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
20000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1074000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-125000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax
972000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax
755000 USD
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1876000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1867000 USD
CY2021Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3000000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1411000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2754000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17010131 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16974100 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
16621 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
20627 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17026752 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16994727 shares
CY2020Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
10924000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
101000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
101000 shares
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
537000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1108000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2757
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2869
CY2021Q1 us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
-61000 USD
CY2020Q1 us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
2253000 USD
CY2021Q1 us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
-61000 USD
CY2021Q1 ubfo Fair Value Option Credit Risk Gross Losses On Assets
FairValueOptionCreditRiskGrossLossesOnAssets
1033000 USD
CY2021Q1 ubfo Fair Value Option Credit Risk Losses On Assets Net
FairValueOptionCreditRiskLossesOnAssetsNet
728000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax
972000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
685000 USD
CY2020Q1 us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
2253000 USD
CY2020Q1 ubfo Fair Value Option Credit Risk Gain On Assets Net Before Tax
FairValueOptionCreditRiskGainOnAssetsNetBeforeTax
1498000 USD
CY2020Q1 ubfo Fair Value Option Credit Risk Gain On Assets Net After Tax
FairValueOptionCreditRiskGainOnAssetsNetAfterTax
1055000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax
755000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
532000 USD
CY2021Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
147340000 USD
CY2021Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
10983000 USD
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
94560000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
4488000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4488000 USD
CY2021Q1 ubfo Maximum Term Of Guarantees
MaximumTermOfGuarantees
P3Y
CY2021Q1 ubfo Minimum Term Of Guarantees
MinimumTermOfGuarantees
P1M
CY2021Q1 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
108035000 USD

Files In Submission

Name View Source Status
0001137547-21-000014-index-headers.html Edgar Link pending
0001137547-21-000014-index.html Edgar Link pending
0001137547-21-000014.txt Edgar Link pending
0001137547-21-000014-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ubfo-20210331.htm Edgar Link pending
ubfo-20210331.xsd Edgar Link pending
ubfo-20210331exhibit311.htm Edgar Link pending
ubfo-20210331exhibit312.htm Edgar Link pending
ubfo-20210331exhibit321.htm Edgar Link pending
ubfo-20210331exhibit322.htm Edgar Link pending
ubfo-20210331_cal.xml Edgar Link unprocessable
ubfo-20210331_def.xml Edgar Link unprocessable
ubfo-20210331_htm.xml Edgar Link completed
ubfo-20210331_lab.xml Edgar Link unprocessable
ubfo-20210331_pre.xml Edgar Link unprocessable